BIGBEAR
PHARMACEUTICAL
Cabozantinib is an oral multi-targeted tyrosine kinase inhibitor with broad-spectrum anticancer activity.
AuthenticGuaranteeFast DeliveryPrivacy Cabozantinib Mechanism of Action1. Inhibits multiple receptor tyrosine kinases (RTKs) that are involved in initiating various intracellular signaling ···【More】
Update: 24 Jul,2026Source: BigbearViews: 79
Cabozantinib Pharmacokinetics1. Absorption(1) Absolute oral bioavailability has not been determined.(2) After oral administration, the median time to ···【More】
Update: 24 Jul,2026Source: BigbearViews: 79
Cabozantinib-Specific Drugs and Foods1. Antifungals, azoles (e.g., itraconazole, ketoconazole, voriconazole): Potent CYP3A4 inhibitors, may increase c···【More】
Update: 22 Jul,2026Source: BigbearViews: 86
Common Adverse Reactions of Cabozantinib1. Cabozantinib capsules (Cometriq) (incidence ≥25%): diarrhea, stomatitis, palmar-plantar erythrodysesthesia ···【More】
Update: 22 Jul,2026Source: BigbearViews: 88
Cabozantinib is an antineoplastic agent belonging to the class of multiple receptor tyrosine kinase inhibitors.Cabozantinib Warnings and Precautions1.···【More】
Update: 22 Jul,2026Source: BigbearViews: 89
Management of Cabozantinib Side Effects for Healthcare ProfessionalsPatients should be closely monitored during the first 8 weeks of treatment, as mos···【More】
Update: 22 Jul,2026Source: BigbearViews: 90
During treatment with Cabozantinib, various side effects may occur. If you are unsure about the severity of any side effect, please consult your docto···【More】
Update: 22 Jul,2026Source: BigbearViews: 86
Cabozantinib StorageStore at 20°C to 25°C (68°F to 77°F). Keep in original packaging to protect from moisture.Cabozantinib Monitoring1. Cardiovascular···【More】
Update: 22 Jul,2026Source: BigbearViews: 87
Cabozantinib Tablets: Adverse Reaction Dose Modifications1. Renal Cell Carcinoma (RCC)(1) Elective surgery: Withhold treatment for at least 28 days be···【More】
Update: 21 Jul,2026Source: BigbearViews: 93
Cabozantinib Pediatric Usual DoseThyroid Cancer-DTC(1) IndicationsUse: For the treatment of pediatric patients aged 12 years and older with locally ad···【More】
Update: 20 Jul,2026Source: BigbearViews: 100
Cabozantinib recommended dosage is closely related to the treated disease and patient age; typically, once daily, with specific dosage strictly follow···【More】
Update: 20 Jul,2026Source: BigbearViews: 99
March 26, 2025--Alameda, CA--(BUSINESS WIRE)Exelixis, Inc. (NASDAQ: EXEL) today announced that the U.S. Food and Drug Administration (FDA) has approve···【More】
Update: 11 May,2026Source: BigbearViews: 170
September 17, 2021--Alameda, CA--(BUSINESS WIRE)Exelixis, Inc. (NASDAQ: EXEL) announced that the U.S. Food and Drug Administration (FDA) has approved ···【More】
Update: 11 May,2026Source: BigbearViews: 131
January 22, 2021--Princeton, NJ--(BUSINESS WIRE)Bristol Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has approv···【More】
Update: 11 May,2026Source: BigbearViews: 152
January 14, 2019--Alameda, CA--(BUSINESS WIRE)Exelixis, Inc. (Nasdaq: EXEL) announced that the U.S. Food and Drug Administration (FDA) has approved ca···【More】
Update: 11 May,2026Source: BigbearViews: 142
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
